Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL
Official Title: A Phase 2a, Multi Centre, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of 12 Weeks Treatment With Oral PXS-4728A on Microglia Activation, as Measured by Posi
Brief Summary: This study is to investigate the safety and efficacy of PXS-4728A as an intervention therapy in participants with iRBD.
This study will be conducted in participants aged 50 to 80 years of age and will investigate a single dose level.